Eximis Surgical is developing a laparoscopic specimen removal system for minimally invasive surgery (MIS) designed to fully contain specimen segmentation and removal. Eximis secured $8.7M in financing from Olympus Innovation Ventures to fund U.S. regulatory and IDE clinical trial activities. We are partnering with Bob Luzzi, VP of R&D of Eximis Surgical, to hire our System Engineering Leader (entry-level up to Staff).
Technology Video: Specimen Segmentation and Removal
This position will be responsible for the algorithm development, electrical data analysis, and understanding the output of the system electrically. Additionally, understanding voltage power delivery, impedance through tissue, and looping feedback into the instruments is important. This person can come in as an individual contributor or will grow and lead a team.
Candidates must be within driving distance of company headquarters for our positions. Relocation assistance is available.
Additional positions available:
Bachelor’s degree in biomedical, electrical, or mechanical engineering. Master’s Degree preferred.
Eximis Surgical Inc., develops innovative technologies for the removal of large specimens during minimally invasive procedures. The company is in the pre-market phase and is actively working towards FDA submission for its first device in the platform. Eximis Surgical’ proprietary technology is designed to provide surgeons a fully automated and contained system that leverages controlled RF energy delivery to segment large tissue specimens for removal through a small incision.
Lifeblood™ supports global MedTech Startups with Talent Acquisition and Fundraising Strategies. We build full-scale startup teams from Board and C-level executives to entry-level individual contributors and from early-stage R&D through multi-national commercialization phases.Approaching two decades of experience in the MedTech industry, our talent acquisition services and team-building efforts are the results of 2,000+ successful hires for 500+ companies in 6 continents. We have facilitated more than $220 million for MedTech startups with our fundraising strategies and global investor network.
People and money are the lifeblood capital of startups. Learn from our entrepreneurs and investors as we demystify raising and investing capital on our MedTech Money Podcast Series.